EP3450434
DEUTERATED DERIVATIVES OF RUXOLITINIB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.6.2013EP published:
24.2.2021EP application number:
18188152.5
EPO information:
European Patent Register
Max expiry date:
13.6.2033
Title:
DEUTERATED DERIVATIVES OF RUXOLITINIB
Timeline
Today
14.6.2013EP application
24.2.2021EP Publication
Owner
Name:
CoNCERT Pharmaceuticals, Inc.Address:
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, US
Inventor
Name:
SILVERMAN, I. RobertAddress:
Arlington, MA 02474, US
Name:
LIU, Julie F.Address:
Lexington, MA 02420, US
Name:
MORGAN, Adam J.Address:
Ashland, MA 01721, US
Name:
PANDYA, BhaumikAddress:
Arlington, MA 02474, US
Name:
HARBESON, Scott L.Address:
Ellenton, FL 34222-2025, US
Priority
Number:
201261660428 PDate:
15.6.2012Country:
US
Number:
201261678795 PDate:
2.8.2012Country:
US
Classification
Categories:
C07D 487/04, C07B 59/00, A61K 31/519, A61P 35/02